国产竞争格局看,健康元、普锐特、长风药业等在集采增量、新产品上市的背景下,份额快速提升,从各公司注册上市管线、集采影响节奏等角度看,我们预计国内头部品牌吸入制剂市占率有望持续提升。
资料来源:wind医药库,上海阳光医药采购网,浙商证券研究所
feel free to call us on
025-85998075
drop us a line anytime at
,
and we’ll get back
soon.
come visit us at 2 qiande road, life science high tech zone, jiang ning district, nanjing, jiangsu province, china